Equitable Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.36M | Sell |
68,588
-6,685
| -9% | -$523K | 0.27% | 73 |
|
2025
Q1 | $5.46M | Buy |
75,273
+2,231
| +3% | +$162K | 0.3% | 65 |
|
2024
Q4 | $5.41M | Buy |
73,042
+7,154
| +11% | +$530K | 0.3% | 69 |
|
2024
Q3 | $4.35M | Buy |
65,888
+52,154
| +380% | +$3.44M | 0.28% | 79 |
|
2024
Q2 | $1.27M | Buy |
13,734
+2,115
| +18% | +$195K | 0.09% | 161 |
|
2024
Q1 | $1.11M | Buy |
11,619
+962
| +9% | +$91.9K | 0.08% | 183 |
|
2023
Q4 | $813K | Buy |
10,657
+5,129
| +93% | +$391K | 0.06% | 209 |
|
2023
Q3 | $383K | Buy |
5,528
+521
| +10% | +$36.1K | 0.03% | 300 |
|
2023
Q2 | $472K | Buy |
5,007
+197
| +4% | +$18.6K | 0.04% | 269 |
|
2023
Q1 | $398K | Hold |
4,810
| – | – | 0.03% | 293 |
|
2022
Q4 | $359K | Buy |
4,810
+1,308
| +37% | +$97.6K | 0.03% | 310 |
|
2022
Q3 | $289K | Hold |
3,502
| – | – | 0.02% | 316 |
|
2022
Q2 | $333K | Buy |
3,502
+202
| +6% | +$19.2K | 0.02% | 314 |
|
2022
Q1 | $388K | Hold |
3,300
| – | – | 0.02% | 287 |
|
2021
Q4 | $428K | Buy |
+3,300
| New | +$428K | 0.03% | 275 |
|
2021
Q3 | – | Sell |
-5,313
| Closed | -$550K | – | 365 |
|
2021
Q2 | $550K | Sell |
5,313
-4,883
| -48% | -$505K | 0.04% | 237 |
|
2021
Q1 | $853K | Hold |
10,196
| – | – | 0.06% | 185 |
|
2020
Q4 | $930K | Buy |
10,196
+413
| +4% | +$37.7K | 0.07% | 185 |
|
2020
Q3 | $781K | Sell |
9,783
-366
| -4% | -$29.2K | 0.07% | 186 |
|
2020
Q2 | $702K | Sell |
10,149
-1,974
| -16% | -$137K | 0.06% | 187 |
|
2020
Q1 | $762K | Buy |
12,123
+8,463
| +231% | +$532K | 0.08% | 171 |
|
2019
Q4 | $285K | Hold |
3,660
| – | – | 0.03% | 248 |
|
2019
Q3 | $268K | Hold |
3,660
| – | – | 0.03% | 250 |
|
2019
Q2 | $225K | Sell |
3,660
-213
| -5% | -$13.1K | 0.02% | 263 |
|
2019
Q1 | $247K | Buy |
+3,873
| New | +$247K | 0.03% | 252 |
|
2018
Q4 | – | Sell |
-3,660
| Closed | -$212K | – | 273 |
|
2018
Q3 | $212K | Buy |
+3,660
| New | +$212K | 0.02% | 280 |
|